News

Vacancy: Post-doc in Biochemistry & Molecular Immunology, LUMC

Our research group is looking for a motivated and excellent postdoc with a strong background in protein analysis and (bio)chemistry and with an interest in innate immunity.

Registration now open! ICI Conference Naturalis Leiden June 10th 2022

Due to the ongoing measures against COVID-19 we have decided to postpone the ICI Conference of 2022, formerly scheduled on Friday March 18th, to Friday June 10th.

Dana Vergoossen awarded for "Best article 2021"

In December, Dana Vergoossen received from the Prinses Beatrix Spierfonds the prestigious award for young Dutch neuromuscular researchers. She was awarded for her paper, published in PNAS (30 March 2021), describing pioneering work in the field of IgG4 antibodies. The prize consists of a cash prize of 1000.

Noel de Miranda will join the KNAW Young Academy

Noel de Miranda is Principal Investigator of the Cancer Immunogenomics group and Associate professor at the LUMC Department of Pathology. He seeks to understand how a patient’s immune system recognizes cancer cells, how cancer cells escape such recognition, and how our knowledge of this behavior can be used to develop effective immunotherapies. As a Young Academic member, his focus will be on promoting sustainable and stimulating academic environments for researchers that are simultaneously inclusive and accessible to society.

Awarded Veni grants December 2021

In December NWO has awarded 89 promising young scientists from the science domains ENW and ZonMw a Veni grant of up to 280,000 euros. This allows the laureates to further develop their own research ideas for a period of three years. Below, awarded research projects in the field of biological immunology are shown.

ICI Conference 18 March 2022

We are pleased to invite you to the next ICI conference to be held March 18 2022 at the Naturalis Biodiversity Center in Leiden.

We are proud to announce the following confirmed speakers:

Unique binding to corona spike protein

After a corona infection, our bodies produce a variety of different antibodies to neutralize the corona virus. Within that broad variety, each antibody appears to bind in their own unique way to the SARS-CoV-2 spike. This was discovered by a research team led by Albert Heck at Utrecht University, together with colleagues at Amsterdam UMC and the Scripps Research Institute. The group published their results in ACS Central Science, which selected the paper as its cover article.

Jeantet-Collen Prize for translational medicine for Ton Schumacher

Immunologist Ton Schumacher from Antoni van Leeuwenhoek, who is also a professor at Leiden University and the Leiden University Medical Centre (LUMC), is to receive the Jeantet-Collen Prize for Translational Medicine 2021.

Registration for the 2021 Chemical Immunology Conference is now open!

This year’s online edition will take place Friday March 19, 2021 from 02.00 PM to 06.00 PM (CET).
Confirmed speakers include:
 

Vacancy: Post-doc Scientist Molecular biology / Biochemistry / Immuno-Oncology

Acute myeloid leukemia (AML) is a devastating disease with a high mortality. Patients often need the immunotherapeutic effect of an allogeneic hematopoietic stem cell transplantation (HCT) to be cured. We have demonstrated that AML patients who are cured after allogeneic HCT develop AML-specific antibody responses. Some of these antibodies with broad reactivity against AML cells of patients have the potential to be further developed into therapeutic antibodies. 

Pages